SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,123.83 -125.56
( -0.17%)

Global Indices

Nasdaq

52,230.09 -658.89
(-1.25%)

Dow Jones

7,644.13 -40.30
(-0.52%)

Hang Seng

62,584.98 -322.86
(-0.51%)

Nikkei 225

10,670.63 -54.40
(-0.51%)

Forex

USD-INR

94.61 0.10
(0.11%)

EUR-INR

106.18 0.08
(0.07%)

GBP-INR

126.70 0.19
(0.15%)

JPY-INR

0.60 0.00
(0.70%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Alivus Life Sciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

543322

INE03Q201024

271.4099527

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ALIVUS

24.63

15313.28

EPS(TTM)

Face Value()

Div & Yield %

50.64

0.4

Back

Ecofinity Atomix reports consolidated net profit of Rs 0.58 crore in the June 2026 quarter

Aug 14,2026

Net profit of Ecofinity Atomix remain constant at Rs 0.58 crore in the quarter ended June 2026 and also during the previous quarter ended June 2025. Sales rose 10.50% to Rs 16.10 crore in the quarter ended June 2026 as against Rs 14.57 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	16.10	14.57	11
OPM %	4.41	5.83	-
PBDT	0.83	0.94	-12
PBT	0.79	0.90	-12
NP	0.58	0.58	0

73,123.83 -125.56 ( -0.17%)

52,230.09 -658.89 (-1.25%)

7,644.13 -40.30 (-0.52%)

62,584.98 -322.86 (-0.51%)

10,670.63 -54.40 (-0.51%)

94.61 0.10 (0.11%)

106.18 0.08 (0.07%)

126.70 0.19 (0.15%)

0.60 0.00 (0.70%)